Brought to you by 
Nanotech Catheter gets rights to Unidym's nanotube IP
27 Aug 2007
Executive Summary
Paragon's Nanotech Catheter Solutions division has licensed exclusive rights to use Arrowhead Research division Unidym's (nanotechnology used in electronics) carbon nanotube IP to develop cardiovascular devices including stents and catheters.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nanotech Catheter gets rights to Unidym's nanotube IP
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice